Endonovo Therapeutics (ENDV) Asset Utilization Ratio (2018 - 2023)
Endonovo Therapeutics has reported Asset Utilization Ratio over the past 9 years, most recently at 0.28 for Q3 2023.
- Quarterly results put Asset Utilization Ratio at 0.28 for Q3 2023, up 2894.96% from a year ago — trailing twelve months through Sep 2023 was 0.28 (up 2894.96% YoY), and the annual figure for FY2022 was 0.08, up 159.8%.
- Asset Utilization Ratio for Q3 2023 was 0.28 at Endonovo Therapeutics, up from 0.24 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for ENDV hit a ceiling of 0.28 in Q3 2023 and a floor of 0.01 in Q2 2022.
- Median Asset Utilization Ratio over the past 5 years was 0.05 (2019), compared with a mean of 0.08.
- Biggest five-year swings in Asset Utilization Ratio: tumbled 86.67% in 2022 and later surged 3600.36% in 2023.
- Endonovo Therapeutics' Asset Utilization Ratio stood at 0.09 in 2019, then tumbled by 33.04% to 0.06 in 2020, then plummeted by 43.19% to 0.04 in 2021, then skyrocketed by 180.78% to 0.1 in 2022, then surged by 182.01% to 0.28 in 2023.
- The last three reported values for Asset Utilization Ratio were 0.28 (Q3 2023), 0.24 (Q2 2023), and 0.18 (Q1 2023) per Business Quant data.